Health Sciences
Ana Maria Crous Tsanaclis
- Professeure agrégée de clinique
-
Faculté de médecine - Département de pathologie et biologie cellulaire
Secondary number:
514 890-8000 #27097
(Travail 1)
Secondary email:
ana.maria.crous.tsanaclis.chum@ssss.gouv.qc.ca
(Travail)
Profile
Research expertise
Thèmes
- Neurodégénération
- Tumeur cérébrale
- Maladies neuro-musculaires
Intérêts de recherche
- Maladies neurodégénératives
- Maladies neuromusculaires
- Tumeurs cérébrales
Affiliations and responsabilities
Research affiliations
Affiliated institutions
- Centre hospitalier de l’Université de Montréal (CHUM)
Professional titles and affiliations
Clinical and professional activities
- Membre de l’Association canadienne des neuropathologistes
- Membre de jury - examinatrice de thèses : 26 au total
Teaching and supervision
Projects
Outreach
Publications and presentations
Communications
- Gadji M, Crous AM, Fortin D, Krcek D, Torchia M, Mai S, Drouin R, Klonisch T. EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts. Eur J Pharmacol 2009; 625:23-30.
- Gadji M, Fortin D, Tsanaclis AMC, Garini Y et al.
- Côté J, Savard M, Bovenzi V, Tremblay L, Tsanaclis AM et al.
- Zucchi FC, Tsanaclis AMC, Moura-Dias Q Jr, Silva CL et al. – Modulation of angiogenic factor VEGF by DNA-hsp65 vaccination in a murine CNS tuberculosis model. Tuberculosis 2013; 93 (3): 373-390.
- Roy-Lacroix ME, Guerard M, Berthiaume M, Rola-Pleszczynski M, Crous Tsanaclis AM, Pasquier JC – Time-dependent effect of in utero inflammation: a longitudinal study in rats. Journal of maternal-fetal & neonatal medicine 2013; 26:789-794.
Disciplines
- Neuropathology
Areas of expertise
- Cerebral Tumors
- Neuromuscular Diseases
- Neurodegenerative Diseases (Neurosciences, Mental Health and Addiction)